The new treatment focuses on the GLP-1 intestinal hormone, but also mimics amylin, the hormone released by the pancreas that suppresses hunger. Read more
Novo Nordisk's shares increased by 7 % after the latest remedy for weight loss manufacturer has shown a promising
